Navigation Links
Anemia Treatment for Cancer Patients Might Not be a Good Idea.

Many patients being treated for cancer complain of feeling weak and tried, and doctors often prescribe //an anemia treatment to relieve these symptoms however a new study suggests otherwise.

Since anemia has been associated with worse prognosis after radiotherapy, the doctors assumed the treatment would make patients feel better and improve results of the therapy, as well.

Not so, report German researchers , their study finds treating anemia in cancer patients with the drug erythropoietin (epoetin beta) may actually interfere with cancer treatment. Patients who did not receive the treatment had about a 60-percent better chance of surviving their cancer without a relapse than those who did receive the treatment.

The study involved 351 patients who received either erythropoietin or a placebo about two weeks before undergoing radiotherapy for head and neck cancers. While the drug was effective in treating the symptoms of anemia among the patients, the poorer outcomes seen in the drug group led researchers to conclude the benefits may not be worth the risks.

Researchers say although epoetin beta efficiently corrects anemia among patients undergoing curative radiotherapy, it is not associated with improved cancer control or survival. On the contrary, erythropoietin might impair disease control when manifest cancer is irradiated. However further research is in progress on this subject.
'"/>




Page: 1

Related medicine news :

1. Anemia may Lead to Physical Decline
2. Anemia Treatment for Cancer Patients
3. Anemia Treatment for Cancer Patients
4. Acute Toxicity Of Nano-Scale Zinc Powder: Severe Renal Damage And Anemia
5. Treatment of Sickle Cell Anemia Using Gene Therapy.
6. Treating Sickle Cell Anemia using Healthy Stem Cells
7. Anemia from Malaria Linked to a Protein MIF
8. EPO Effective For Cancer Patients Suffering From Anemia
9. Amgen introduces Autoinjector For Treating Anemia
10. Anemia Affects Both Body and Mind
11. Exercise alleviates Anemia in Breast cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/22/2018)... ANGELES (PRWEB) , ... July 20, 2018 , ... Cosmetic Town, a Los Angeles based ... easier for patients. The website is starting the publication of a series of lists that ... , According to the senior editor of Cosmetic Town , “San Diego is often ...
(Date:7/22/2018)... ... July 21, 2018 , ... In an upcoming episode of “On Demand,” host ... Medicine is a type of medicine that considers the well-being the whole person when ... is a discipline that hones in on the curative relationship between the patient and ...
(Date:10/13/2017)... ... October 13, 2017 , ... ProVest Insurance Group, a family ... and Raleigh regions, is organizing an extended charity drive to benefit the family ... abnormality. , After struggling since birth with several health challenges, T.J. was later ...
(Date:10/13/2017)... , ... October 13, 2017 , ... While it’s often ... a problem. Fortunately, an inventor from Austin, Texas, has identified a solution. , She ... in darkness or restricted lighting. As such, it eliminates the need to turn on ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading ... Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly ... CBD form that can be easily incorporated into liquid products, while reducing costs to ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host ... webcast on Friday, November 3, 2017, beginning at 7:00 ... approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... performance and guidance for 2018, Hill-Rom executives will also ... performance, and long-range financial outlook through 2020. ...
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: